News & Magazines

Quick Reads about Wellness
View All
STAT
6 min read
Psychology

This Biotech Aims To Transform The Diagnosis Of Mental Illness. Michael Phelps Backs It. Can It Really Work?

A small Australian biotech has drawn big-name backers — including swimming superstar Michael Phelps — to its audacious goal: to develop a quick, cheap, and objective way to diagnose an array of mental illnesses. The tool would be a stunning breakthrough in the field of mental health —  if it works. And there’s the rub. Researchers have been trying for decades to find reliable biomarkers for mental illness — that is, tangible biological clues that conclusively indicate whether a person has a particular psychiatric disease. Effort after effort has failed, leaving doctors to diagnose such conditi
STAT
5 min read
Wellness

Forget Sharks: 7 Things In The Water Swimmers Should Actually Fear

It’s shark season — primarily on cable TV. As the decades-long tradition of “Shark Week” approaches, you can expect once again to hear of “serial killer” sharks, attacks near major coastal cities, and menacing, massive shark swarms. But, as you probably also know, shark attacks are incredibly unlikely. You’re 75 times more likely to be killed by lightning than by a shark. On average, one person dies of a shark attack every other year in the United States. But just when you thought it was safe to go back into the water … just kidding, it’s still mostly safe. But swimmers face real risks that ar
STAT
6 min read
Science

87 Experimental Therapies For Glioblastoma Are In The Works. Some Might Help McCain Now

Glioblastoma, the brain cancer that Sen. John McCain has, is invariably — and accurately — described as aggressive and as having a poor prognosis: Not even Sen. Edward Kennedy or Beau Biden, with access to the best care and most cutting-edge therapies in the world, beat it. Recent advances, however, have persuaded some scientists that effective treatments are on the horizon — and some might even help McCain live longer than earlier patients did.  “We’ve learned a tremendous amount about the biology of this cancer,” said Dr. David Reardon, director of neuro-oncology at Boston’s Dana-Farber Canc